Company-wide revenue
Reported revenue in 2021 ¥120.31B Reported revenue in 2025 ¥163.81B
- growth amount
- +¥43.5B
- growth annualized
- +8.0%
- growth total
- +36.2%
Japanese company profile · 7679
YAKUODO HOLDINGS Co.,Ltd.
In its FY2025 public filing, YAKUODO HOLDINGS Co.,Ltd. reports Drugstore Business. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社薬王堂ホールディングス
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
YAKUODO HOLDINGS Co.,Ltd.'s largest reported business by revenue in FY2025 was Drugstore Business.
The business with the highest reported segment profit in FY2025 was Drugstore Business.
FY2025 · fiscal year ended February 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended February 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Drugstore Business
- ドラッグストア事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Drugstore Business
- ドラッグストア事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Drugstore Business | ¥120.31B | ¥128.79B | ¥142.24B | ¥151.96B | ¥163.81B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Drugstore Business
Reported revenue in 2021 ¥120.31B Reported revenue in 2025 ¥163.81B
- growth amount
- +¥43.5B
- growth annualized
- +8.0%
- growth total
- +36.2%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended February 2026
The source document may be in Japanese.
Filing ID: S100Y4K3
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.